Quentin Kimmerlin

6PUBLICATIONS
17CO-AUTHORS
Haematological tumoursMolecular targetsMetabolic medicineBiomaterialsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 30, 2026
A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.

|Mar 12, 2025
Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F.

Marc Usart, Quentin Kimmerlin, Jan Stetka

|Jan 31, 2024
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN.

Marc Usart, Nils Hansen, Jan Stetka

|Aug 26, 2022
Loss of α4A- and β1-tubulins leads to severe platelet spherocytosis and strongly impairs hemostasis in mice.

Quentin Kimmerlin, Sylvie Moog, Alexandra Yakusheva

|Jan 07, 2022
Glycoprotein V : the unsolved GPV puzzle.

Quentin Kimmerlin, Sylvie Moog, Catherine Ravanat

|Oct 27, 2021
Mutations in the most divergent α-tubulin isotype, α8-tubulin, cause defective platelet biogenesis.

Quentin Kimmerlin, Arnaud Dupuis, Satish Bodakuntla

Pageof 1

Frequent Collaborators

3 joint publications

Radek C Skoda

2 joint publications

Marc Usart

2 joint publications

Jan Stetka

2 joint publications

Alexandre Guy